Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 7
Submit an article Journal homepage
154
Views
11
CrossRef citations to date
0
Altmetric
Letters to the Editor

MicroRNA let-7f is down-regulated in patients with refractory acute myeloid leukemia and is involved in chemotherapy resistance of adriamycin-resistant leukemic cells

Chong-Wen DaiDepartment of Hematology, Institute of Molecular Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaCorrespondence[email protected] [email protected]
,
Qing-Wei BaiDepartment of Hematology, Institute of Molecular Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China;Department of Hematology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China
,
Guang-Sen ZhangDepartment of Hematology, Institute of Molecular Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaCorrespondence[email protected] [email protected]
,
Yi-Xiong CaoDepartment of Hematology, Institute of Molecular Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China;Department of Hematology, The First Affiliated Hospital, South China University, Hengyang, Hunan, China
,
Jian-Kai ShenDepartment of Hematology, Institute of Molecular Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
,
Min-Fei PeiDepartment of Hematology, Institute of Molecular Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
&
C. Cameron YinDepartment of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
 show all
Pages 1645-1648 | Received 05 Aug 2013, Accepted 18 Sep 2013, Published online: 12 Nov 2013

References

  • Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res 2005;65:3509–3512.
  • Zheng T, Wang J, Chen X, et al. Role of microRNA in anticancer drug resistance. Int J Cancer 2010;126:2–10.
  • Miao ZH, Ding J. Transcription factor c-Jun activation represses mdr-1 gene expression. Cancer Res 2003;63:4527–4532.
  • Cao YX, Dai CW, Zhang GS. Screening for drug resistance related microRNAs in K562 and K562/A02 cell lines. Zhonghua Xue Ye Xue Za Zhi. 2010 ;31:361–365.
  • Jerome T, Laurie P, Louis B, et al. Enjoy the silence: the story of let-7 microRNA and cancer. Curr Genomics 2007;8:229–233.
  • Garofalo M, Quintavalle C, Romano G, et al. miR221/222 in cancer: their role in tumor progression and response to therapy. Curr Mol Med 2012;12:27–33.
  • van Jaarsveld MT, Helleman J, Berns EM, et al. MicroRNAs in ovarian cancer biology and therapy resistance. Int J Biochem Cell Biol 2010;42:1282–1290.
  • Kovalchuk O, Filkowski J, Meservy J, et al. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther 2008;7: 2152–2159.
  • Zhu H, Wu H, Liu X, et al. Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 2008;76:582–588.
  • Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005;33:el79.
  • Nishi M, Eguchi-Ishimae M, Wu Z, et al. Suppression of the let-7b microRNA pathway by DNA hypermethylation in infant acute lymphoblastic leukemia with MLL gene rearrangements. Leukemia 2013;27:389–397.
  • Pelosi A, Careccia S, Lulli V, et al. MiRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia. Oncogene 2013;32:3648–3654.
  • Shibahara Y, Miki Y, Onodera Y, et al. Aromatase inhibitor treatment of breast cancer cells increases the expression of let-7f, a microRNA targeting CYP19A1. J Pathol 2012;227:357–366.
  • Liang S, He L, Zhao X, et al. MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PLoS One 2011;6:e18409.
  • Ricarte-Filho JC, Fuziwara CS, Yamashita AS, et al. Effects of let-7 microRNA on cell growth and differentiation of papillary thyroid cancer. Transl Oncol 2009;2:236–241.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.